Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | BMY | GILD | MRNA |
| Company | Vertex Pharmaceutic | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 483.78 | 336.80 | 49.78 | 84.25 | 71.29 |
| High | 483.78 | 336.80 | 49.78 | 84.25 | 71.29 |
| Low | 473.75 | 336.80 | 49.78 | 84.25 | 71.29 |
| Last | 477.99 | 336.94 | 49.56 | 84.43 | 70.45 |
| Change | +3.83 | +4.02 | -0.18 | +0.54 | +0.59 |
| % Change | +0.81% | +1.21% | -0.36% | +0.64% | +0.84% |
| Volume | 868,200 | 4,704 | 168,323 | 67,062 | 40,383 |
| 20-Day Average Volume | 980,545 | 1,679,610 | 8,176,526 | 6,258,373 | 5,275,594 |
| Previous Close | 481.26 | 332.92 | 49.74 | 83.89 | 69.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 480.27 | 329.63 | 49.13 | 80.09 | 75.25 |
| 20-Day Raw Stochastic | 34.05% | 89.00% | 74.90% | 93.29% | 31.64% |
| 20-Day Relative Strength | 47.32% | 58.29% | 57.73% | 72.54% | 35.49% |
| Weighted Alpha | +32.08 | +27.54 | -9.29 | +18.92 | -31.47 |
| Today's Opinion | 40% Buy | 96% Buy | 72% Buy | 88% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 88% Buy | 72% Buy | 88% Buy | 88% Sell |
| Last Month's Opinion | 88% Buy | 88% Buy | 40% Buy | 56% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.12% since 09/11/24 | +2.04% since 09/12/24 | +3.19% since 09/12/24 | +1.31% since 09/12/24 | +2.31% since 09/12/24 |
| Low | 468.46 on 09/12/24 | 327.15 on 09/13/24 | 48.20 on 09/13/24 | 81.57 on 09/13/24 | 65.55 on 09/13/24 |
| High | 490.15 on 09/16/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.52 on 09/18/24 | 75.37 on 09/17/24 |
| 1-Month | |||||
| %Chg | -0.67% since 08/16/24 | +2.69% since 08/19/24 | +0.97% since 08/19/24 | +13.16% since 08/19/24 | -20.75% since 08/19/24 |
| Low | 460.69 on 09/11/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 | 64.11 on 09/12/24 |
| High | 500.25 on 08/30/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 89.80 on 08/20/24 |
| 3-Month | |||||
| %Chg | +1.47% since 06/18/24 | +10.07% since 06/18/24 | +21.98% since 06/18/24 | +33.41% since 06/18/24 | -46.51% since 06/18/24 |
| Low | 458.04 on 08/13/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 64.11 on 09/12/24 |
| High | 510.64 on 08/01/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 138.07 on 06/25/24 |
| 6-Month | |||||
| %Chg | +15.26% since 03/18/24 | +23.95% since 03/19/24 | -3.90% since 03/19/24 | +14.77% since 03/19/24 | -32.18% since 03/19/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 64.11 on 09/12/24 |
| High | 510.64 on 08/01/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 170.47 on 05/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 122,358,416 | 178,589,936 | 100,827,960 | 104,514,608 | 26,773,144 |
| Shares Outstanding, K | 258,053 | 536,435 | 2,027,100 | 1,245,853 | 383,240 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 2,645,600,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 241,000,000 |
| Last Quarter Net Income | -3,593,600,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,279,000,000 |
| 60-Month Beta | 0.40 | 0.61 | 0.46 | 0.18 | 1.67 |
| Per-Share Information | |||||
| Most Recent Earnings | -12.83 on 08/01/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -3.33 on 08/01/24 |
| Latest Earnings Date | 11/04/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 36.12 | 17.67 | 0.00 |